Table-III.
Comparison of INF-γ, TGF-β1, IL-6 and IL-18 between the two groups (x±s).
| Group | Time | No. of cases | INF-γ(pg/ml) | TGF-β1(ng/ml) | IL-6(pg/ml) | IL-18(pg/ml) |
|---|---|---|---|---|---|---|
| Experimental group | Before treatment | 49 | 120.64±13.49 | 2.01±0.18 | 97.68±11.36 | 236.84±40.63 |
| 1 month after treatment | 49 | 72.63±10.31* | 2.39±0.17* | 48.69±7.29* | 89.36±13.08* | |
| 3 months after treatment | 49 | 59.48±9.47*# | 2.96±0.23*# | 37.65±6.89*# | 40.37±4.84*# | |
| Control group | Before treatment | 49 | 121.36±11.98 | 2.03±0.17 | 97.84±11.17 | 240.85±35.98 |
| 1 month after treatment | 49 | 70.69±10.85* | 2.43±0.18* | 46.86±8.30* | 86.96±12.30* | |
| 3 months after treatment | 49 | 64.63±8.31* | 2.80±0.18* | 43.65±5.27* | 55.36±6.85* |
Note:
*
p<0.05 compared with that before treatment in this group;
#
p<0.05 compared with that in the control group at the same time.